ESTRO37_ProgrammeBook

point of view, uncertainties like registration errors, changes in tumor volumes and their impact on image registration will be discussed. Furthermore radiobiological aspects of target dose assessment will be reviewed. As organs at risk change during treatment and they are not homogenously exposed, the importance of organ substructure will be addressed. Finally, knowledge gained from patient population based organ at risk assessments will be shared. Chair: D. Georg (Austria) Co-Chair: T. Alderliesten (The Netherlands)

MONDAY 23 APRIL 2018

08:45 > Do the current software solutions serve our needs? Speaker: M. Thor (USA)

 SP-0462

09:10 > Dose mapping from the target point of view Speaker: E.M. Vasquez Osorio (United Kingdom)

 SP-0463

09:35 > Dose mapping from the organ at risk point of view Speaker: A. McWilliam (United Kingdom)

SP-0464

SYMPOSIUM Stereotactic RT and radiosurgery 08:45 - 10:00  |  ROOM 129-130 This session will discuss the evidence for SRT/SRS/SBRT and the clinical implementation of these techniques. The presenters will discuss the background to a variety of treatment sites including intra-cranial, lung and intra-abdominal lesions. Clinical indications for both benign and malignant lesions will be considered, including rationale for oligometastatic disease. The session will include discussion on the optimal technique for delivery, including; different treatment platforms and technologies, treatment planning methods, methods of dose prescribing and calculation of appropriate margins. New and emerging evidence will be presented and future areas of interest.

Chair: A. Duffton (United Kingdom) Co-Chair: R.L. Christiansen (Denmark)

08:45 > SBRT in the management of oligometastatic disease Speaker: Y.M. Tsang (United Kingdom) 09:10 > Intracranial lesions and dedicated Linac radiosurgery Speaker: M. Hoogeman (The Netherlands)

SP-0465

SP-0466

09:35 > Stereotactic Radiotherapy for Benign Disease Speaker: S. Barrett (Ireland)

SP-0467

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

146